Back to Search
ALBERT RIDGEWAY, MD
MD
Specialist
NPI: 1326013558IndividualAccepts Medicare
Specialties, Licenses & Credentials
SpecialistPrimary
Specialist
Code: 174400000X
17451(AL)
Education
VANDERBILT UNIVERSITY SCHOOL OF MEDICINE
Class of 1992
Research & Publications (9)
P53 levels determine outcome during beta-catenin tumor initiation and metastasis in the mammary gland and male germ cells.
PMID 16434961·Oncogene·2006
7-preclinical
Pax3 is essential for skeletal myogenesis and the expression of Six1 and Eya2.
PMID 11262400·J Biol Chem·2001
8-other
Wnt signaling regulates the function of MyoD and myogenin.
PMID 10915791·J Biol Chem·2000
7-preclinical
Myocyte enhancer factor 2C and myogenin up-regulate each other's expression and induce the development of skeletal muscle in P19 cells.
PMID 10617583·J Biol Chem·2000
7-preclinical
HDAC activity regulates entry of mesoderm cells into the cardiac muscle lineage.
PMID 17038545·J Cell Sci·2006
7-preclinical
A cytoskeleton-based functional genetic screen identifies Bcl-xL as an enhancer of metastasis, but not primary tumor growth.
PMID 15064711·Oncogene·2004
7-preclinical
Disruption of Meox or Gli activity ablates skeletal myogenesis in P19 cells.
PMID 15039437·J Biol Chem·2004
7-preclinical
Inhibition of p38 MAPK signaling promotes late stages of myogenesis.
PMID 12771182·J Cell Sci·2003
7-preclinical
Attenuation of interleukin 8-induced nasal inflammation by an inhibitor peptide.
PMID 11316659·Am J Respir Crit Care Med·2001
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 342 COX BLVD
SHEFFIELD, AL 35660 - Phone
- (256) 383-4473
Quick Facts
- NPI
- 1326013558
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 34
- Publications
- 9
Are you this provider?
Claim Your Profile